Skip to Main Content

Matthew Kukla

Senior Health Economist | PhD

A Senior Health Economist in our Health Analytics Practice Area, Matt has over a decade of experience working with government agencies and private health insurers, both within the US and globally, to improve health system performance. He provides strategic and analytic guidance to state insurance departments, independent agencies, and commercial insurers that enables them to make evidence-based decisions for improving health care coverage and affordability. 

Matt's work at BerryDunn focuses on designing and evaluating health financing policies (government) and strategies (private insurers). Matt synthesizes best practices and distills complex, quantitative evidence in ways that help stakeholders make strategic decisions around health insurance markets, payment systems, pricing models, and benefit design. A member of the BerryDunn Recovery Advisory Team, Matt helps clients understand the impact of COVID-19 on healthcare costs and insurance markets, as well as enhance value-based payment systems in response to the outbreak.

A Senior Health Economist in our Health Analytics Practice Area, Matt has over a decade of experience working with government agencies and private health insurers, both within the US and globally, to improve health system performance. He provides strategic and analytic guidance to state insurance departments, independent agencies, and commercial insurers that enables them to make evidence-based decisions for improving health care coverage and affordability. 

Matt's work at BerryDunn focuses on designing and evaluating health financing policies (government) and strategies (private insurers). Matt synthesizes best practices and distills complex, quantitative evidence in ways that help stakeholders make strategic decisions around health insurance markets, payment systems, pricing models, and benefit design. A member of the BerryDunn Recovery Advisory Team, Matt helps clients understand the impact of COVID-19 on healthcare costs and insurance markets, as well as enhance value-based payment systems in response to the outbreak.

In Matt's previous role at a government consulting firm, he oversaw several CMS/CMMI evaluations and state-wide policy initiatives. These included independent evaluations of payment demonstrations (e.g., CJR bundled payments) and cost benchmarking for Maryland’s population-based payment models (e.g., Total Cost of Care). He also managed a multi-million dollar portfolio to redesign national health insurance agencies and payment systems across Asia.

Matt has held additional leadership positions at a global multilateral organization and an academic institution. His work entailed evaluating Florida’s Medicaid managed care program and analyzing stabilization techniques across European insurance markets to inform healthcare legislation in the U.S.

Experience Highlights

Matt helps clients with:

  • Strengthening public and private insurance markets (e.g., Medicare Advantage, ACA)
  • Designing provider payment models, including value-based payments
  • Evaluating and forecasting the impact of health financing legislation on coverage and costs
  • Health financing policies and regulations
  • Innovative pricing and benefit design models
  • Strategic planning for insurance carriers

Publications

News

EDUCATION

BA, cum laude, Economics, Minors in Psychology and Biology, DePauw University

PhD, summa cum laude, Health Services Research, Specialization in Health Economics and Financing, University of Florida
 

CERTIFICATIONS

  • PhD